In order to observe the possible effect of compound DBH2 to the intracellular level of PARP1 in CML cells, the expression of PARP1 protein in K562 cells was measured after compound DBH2 treatment. This evidence concerns the gene PARP1 and chronic myelogenous leukemia, BCR-ABL1 positive.